Collagenase expression in ovarian cancer cell lines

Gynecologic Oncology

Volumn 65, Issue 1, 1997, Pages 78-82

  Moore, David H ^a   Allison, Bernadette ^a   Look, Katherine Y ^a   Sutton, Gregory P ^a   Bigsby, Robert M ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; COLLAGENASE; MATRIX METALLOPROTEINASE; PHORBOL ESTER; PROTEIN KINASE C;

ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; ENZYME ACTIVITY; ENZYME ANALYSIS; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; OVARY CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; TERATOCARCINOMA; TRANSCRIPTION REGULATION;

EID: 0031128265     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4628     Document Type: Article

References (27)

1. 1. Kohn EC, Liotta LA: Invasion and metastasis: New approaches to an old problem. Oncology 7:47-52, 1993
2. 2. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64:327-336, 1991
3. 3. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI: SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264:17213-17221, 1989
4. 4. Campo E, Merino MJ, Tavassoli FA, Charonis AS, Stetler-Stevenson WG, Liotta LA: Evaluation of basement membrane components and the 72 kDa type IV collagenase in serous tumors of the ovary. Am J Surg Pathol 16:500-507, 1992
5. 5. Autio-Harmainen H, Karttunen T., Hurskainen T, Hoyhtya M, Kauppila A, Tryggvason K: Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors. Lab Invest 69:312-321, 1993
6. 6. Tamakoshi K, Kikkawa F, Nawa A, Maeda O, Kawai M, Sugamuma N, Yamagata S, Tomoda Y: Different pattern of zymography between human gynecologic normal and malignant tissues. Am J Obstet Gynecol 171:478-484, 1994
7. 7. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614, 1992
8. r 92,000 gelatinase secreted by normal and malignant human cells: Isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res 50:6162-6170, 1990
9. 9. Laemmli UK: Cleavage of structure proteins during the assembly of the head of bacteriophage. Nature 227:680-685, 1970
10. 10. Liotta LA, Tryggvason K, Garbisa S, Gehron-Robey P, Abe S: Partial purification and characterization of a neutral protease which cleaves type IV collagenase genes. Genomics 9:429-434, 1991
11. 11. Salo T, Liotta LA, Tryggvason K: Purification and characterization of a murine basement membrane collagen degrading enzyme secreted by metastatic tumor cells. J Biol Chem 258:3058-3063, 1983
12. 12. Collier IE, Bruns GAP, Goldberg GI, Gerhard DS: On the structure and chromosome location of the 72- and 92-kDa human type IV collagenase genes. Genomics 9:429-434, 1991
13. 13. Huhtala P, Tuuttila A, Chow LT, Lohi J, Keski-Oja J, Tryggvason K: Complete structure of the human gene for 92-kDa type IV collagenase: Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J Biol Chem 266:16485-16490, 1991
14. 14. Huhtala P, Chow LT, Tryggvason K: Structure of the human type IV collagenase gene. J Biol Chem 265:11077-11082, 1990
15. 15. Mignatti P, Robbins E, Rifkin DB: Tumor invasion through the human amniotic membrane: Requirement for proteinase cascade. Cell 47:487-498, 1986
16. 16. Stetler-Stevenson WG, Krutzsch HC, Liotta LA: Tissue inhibitor of metalloproteinase (TIMP-2): A new member of the metalloproteinase inhibitor family. J Biol Chem 264:17374-17378, 1989
17. 17. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T: Matrix metalloproteinase 9 (92-kDa gelatinase/ type IV collagenase) from HT1080 fibrosarcoma cells. J Biol Chem 267:21712-21719, 1992
18. 18. Welgus HG, Jeffrey JJ, Eisen AZ, Roswit WT, Stricklin GP: Human skin fibroblast collagenase: Interaction with substrate and inhibitors. Collagen Relat Res 5:167-179, 1985
19. 19. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA: Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 265:13933-13938, 1990
20. 20. Khokha R: Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinase-1. J Natl Cancer Inst 86:299-304, 1994
21. 21. Tsuchiya Y, Sato H, Endo Y, Okada Y, Mai M, Sasaki T, Seiki M: Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo. Cancer Res 53:1397-1402, 1993
22. 22. Davies R, Brown PD, East N, Crimmin MJ, Balkwill FR: Synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 53:2087-2091, 1993
23. 23. Aznavoorian S, Murphy AN, Stetler-Stevenson WG, Liotta LA: Molecular aspects of tumor cell invasion and metastasis. Cancer 71:1368-1383, 1993
24. 24. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239-3245, 1987
25. 25. Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, Laurie GW, Martin GR: Basement membrane complexes with biological activity. Biochemistry 25:312-318, 1986
26. 26. Nishizuka Y: Studies and perspectives of protein kinase C. Science 233:305-312, 1986
27. 27. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614, 1992